The importance of dysmorphology in the identification of new human teratogens

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 157, Issue 3, 2011, Pages 188-194

  Jones, Kenneth Lyons ^a   Carey, John C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Astute clinician; Case reports; Dysmorphology; Mycophenolate mofetil; Teratogen information service; Teratology

Indexed keywords

ALCOHOL; AMINOPTERIN; AMOXICILLIN; ANTIOBESITY AGENT; CARBAMAZEPINE; FENFLURAMINE; FLUCONAZOLE; FLUOXETINE; ISOTRETINOIN; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; PENICILLAMINE; PHENTERAMINE; PHENTERMINE; RETINOIC ACID; TERATOGENIC AGENT; UNCLASSIFIED DRUG; VALPROIC ACID; WARFARIN;

ANOPHTHALMIA; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; COHORT ANALYSIS; COLOBOMA; COMBINATION CHEMOTHERAPY; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; EMBRYOPATHY; GRAFT REJECTION; HUMAN; HYPERTHERMIA; LUMBOSACRAL MENINGOMYELOCELE; LUPUS VULGARIS; MEDICAL INFORMATION; METHODOLOGY; MICROPHTHALMIA; MICROTIA; NAIL HYPOPLASIA; NONHUMAN; OBESITY; PREGNANCY DIABETES MELLITUS; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPINE MALFORMATION; SPONTANEOUS ABORTION; SYNDROME CHARGE; TERATOGENICITY; TERATOLOGY; UNSPECIFIED SIDE EFFECT; VALVULAR HEART DISEASE; VARICELLA ZOSTER VIRUS; X RAY;

ABNORMALITIES, DRUG-INDUCED; DATA COLLECTION; FEMALE; HUMANS; PHARMACEUTICAL PREPARATIONS; PREGNANCY; PROSPECTIVE STUDIES; TERATOGENS;

EID: 79960562605     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30311     Document Type: Article

References (28)

1. Adam MP, Manning MA, Beck AE, Kwan A, Enns GM, Clericuzio C, Hoyme HE. 2003. Methotrexate/misoprostol embryopathy: Report of four cases resulting from failed medical abortion. Am J Med Genet Part A 123A: 72-78.
2. Allanson JE, Biesecker LG, Carey JC, Hennekam RRCM. 2009. Elements of morphology: Introduction. Am J Med Genet Part A 149A: 2-5.
3. Antiretroviral Pregnancy Registry Steering Committee: Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2010. Wilmington, NC Registry Coordinating Center, December 2010. Available at.
4. Armenti VT, Daller JH, Constantinescu S, Silva P, Radomski JS, Moritz MJ, Gaughan WJ, McGrory CH, Coscia LA. 2006. Report from the National Transplantation Pregnancy Registry: Outcomes of pregnancy after transplantation. In: P.I. Terasaki, editor. Clin Transpl Terasaki Foundation Laboratory, Los Angeles (2007) 57-70.
5. Briggs GG, Freeman RK, Yaffe SJ. 2011. Drugs in pregnancy and lactation, 9th edition. Philadelphia: Lippincott, Williams and Wilkins.
6. Carey JC, Martinez L, Balken E, Leen-Mitchell M, Robertson J. 2009. Determination of human teratogenicity by the astute clinician method: Review of illustrative agents and a proposal of guidelines. Birth Defects Res Part A 85: 63-68.
7. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. 1998. Maternal fever and birth outcome: A prospective study. Teratology 58: 251-257.
8. Chambers CD, Braddock SR, Briggs GG, Einarson A, Johnson YR, Miller RK, Polifka JE, Robinson LK, Stepanuk K, Lyons Jones K. 2001. Post marketing surveillance for human teratogenicity: A model approach. Teratology 64: 252-261.
9. Chambers CD, Johnson DL, Robinson LK, Braddock SL, Xu R, Lopez-Jimenez J, Mirrasoul N, Salas E, Luo YJ, Jin S, Jones KL. 2010. Birth outcomes in women who have taken leuflunomide during pregnancy. Arthritis Rheum 62: 1494-1503.
10. Chernoff GF, Jones KL, Kelley C. 1986. The California Teratogen Registry: Five and one-half years of operational experience. J Perinatol 6: 44-47.
11. Edwards MJ, Shiota K, Smith MSR, Walsh DA. 1995. Hyperthermia and birth defects. Reprod Toxicol 9: 411-425.
12. Holmes LB, Wyszynski D. 2004. North American antiepileptic drug pregnancy registry. Epilepsia 45: 1465.
13. Jones KL, Smith DW, Ulleland CN, Streissguth AP. 1973. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet 1: 1267-1271.
14. Jones KL, Lacro RV, Johnson KA, Adams J. 1989. Pattern of malformation in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320: 1661-1666.
15. Jones KL, Johnson KA, Chambers CD. 1994. Offspring of women infected with varicella during pregnancy: A prospective study. Teratology 49: 29-32.
16. Jones KL, Johnson KA, Dick LM, Felix RJ, Kao KK, Chambers CD. 2002. Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine. Teratology 65: 125-130.
17. Jorde L, Carey JC, Bamshad M, White R. 2010. Medical genetics. St. Louis: Mosby/Elsevier Science. p 305.
18. Laforet EG, Lynch CL. 1947. Multiple congenital defects following maternal varicella: Report of a case. N Engl J Med 235: 534-537.
19. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr, Lott IT, Richard JM, Sun SC. 1985. Retinoic acid embryopathy. N Engl J Med 313: 837-841.
20. Lin A, Strauss A, Nguyen S, Rawson K, Kimonis VE. 2011. An additional patient with mycophenolate mofetil embryopathy: Cardiac and facial analyses. Am J Med Genet Part A 155A: 748-756.
21. Loureiro KD, Kao KK, Jones KL, Alvardo S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD. 2005. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet Part A 136A: 117-121.
22. Perez-Aytes A, Ledo A, Boso V, Sáenz P, Roma E, Poveda JL, Vento M. 2008. In utero exposure to mycophenolate mofetil: A characteristic phenotype? Am J Med Genet Part A 146A: 1-7.
23. Rosa FW. 1991. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Eng J Med 324: 674-677.
24. Shepard TH. 1994. Proof of human teratogenicity. Teratology 50: 97-98.
25. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. 2006. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation 82: 1698-1702.
26. Smith DW. 1966. Dysmorphology (teratology). J Pediatr 69: 1150-1169.
27. Stone KM, Reiff-Eldridge R, White AD, Cordero JF, Brown Z, Alexander ER, Andrews EB. 2004. Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol 70: 201-207.
28. Wyszynski D. 2009. Pregnancy exposure registries: Academic opportunities and industry responsibility. Birth Defects Res Part A 85: 93-101.